• CAR T Cells and T-Cell Therapies for Cancer

  • 2024/11/04
  • 再生時間: 18 分
  • ポッドキャスト

CAR T Cells and T-Cell Therapies for Cancer

  • サマリー

  • CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.”

    Related Content:

    • CAR T Cells and T-Cell Therapies for Cancer
    • Translational Science Reviews—A New JAMA Review
    続きを読む 一部表示

あらすじ・解説

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.”

Related Content:

  • CAR T Cells and T-Cell Therapies for Cancer
  • Translational Science Reviews—A New JAMA Review

CAR T Cells and T-Cell Therapies for Cancerに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。